Literature DB >> 14758296

Electrical twitch-obtaining intramuscular stimulation in lower back pain: a pilot study.

Jennifer Chu1, Ka-fai Yuen, Bo-han Wang, Rai-chi Chan, Ira Schwartz, Duncan Neuhauser.   

Abstract

OBJECTIVES: To determine if electrical twitch-obtaining intramuscular stimulation (ETOIMS) provides greater myofascial lower back pain relief than muscle stimulation or skin stimulation.
DESIGN: In this single-blinded, crossover, pilot trial performed at a university-affiliated outpatient rehabilitation medicine department in Taiwan, 12 acupuncture-naive patients with lower back pain of 3-60 mos duration received one crossover treatment every 2 wks by monopolar needle electrode insertion at bilateral T10-S1 levels to: (1) paraspinal muscles, (2) overlying skin, and (3) paraspinal muscles with ETOIMS applied via the needle electrode at individual treatment sites. A total of 30 manual insertions per side per treatment were performed, with withdrawal after 2 secs. Beginning 1 wk before each trial and continuing until 2 wks after, patients completed a visual analog scale twice daily. In addition, on the day of treatment, patients received a physical examination and completed a visual analog scale both before and after treatment.
RESULTS: Significant and immediate reduction in the visual analog scale levels was noted only with ETOIMS. Immediate improvement occurred in one of nine physical tests with muscle stimulation and ETOIMS only. In the 2 wks after treatment, absolute visual analog scale levels for ETOIMS were significantly lower than muscle stimulation and skin stimulation. ETOIMS resulted in a greater percentage of pain relief in the first week after treatment, although it was not statistically significant from muscle stimulation and skin stimulation.
CONCLUSIONS: ETOIMS provided significantly greater immediate and sustained myofascial lower back pain relief than muscle stimulation and skin stimulation. Although a greater percentage of pain reduction occurred with ETOIMS, it was not statistically significant.

Entities:  

Mesh:

Year:  2004        PMID: 14758296     DOI: 10.1097/01.PHM.0000107485.86594.8B

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  8 in total

Review 1.  Treatment of myofascial pain syndrome.

Authors:  Chang-Zern Hong
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Brain manifestation and modulation of pain from myofascial trigger points.

Authors:  David M Niddam
Journal:  Curr Pain Headache Rep       Date:  2009-10

3.  Myofascial pain syndrome: a treatment review.

Authors:  Mehul J Desai; Vikramjeet Saini; Shawnjeet Saini
Journal:  Pain Ther       Date:  2013-02-12

4.  Needling therapy for myofascial pain: recommended technique with multiple rapid needle insertion.

Authors:  Li-Wei Chou; Yueh-Ling Hsieh; Ta-Shen Kuan; Chang-Zern Hong
Journal:  Biomedicine (Taipei)       Date:  2014-08-02

5.  Comparison of the Effects of Ultrasound-Guided Interfascial Pulsed Radiofrequency and Ultrasound-Guided Interfascial Injection on Myofascial Pain Syndrome of the Gastrocnemius.

Authors:  So Min Park; Yun Woo Cho; Sang Ho Ahn; Dong Gyu Lee; Hee Kyung Cho; Sung Yup Kim
Journal:  Ann Rehabil Med       Date:  2016-10-31

6.  Comparison between ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial block with local anesthetic in myofascial pain syndrome of trapezius muscle.

Authors:  Ik Tae Cho; Yun Woo Cho; Sang Gyu Kwak; Min Cheol Chang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

7.  Probable mechanisms of needling therapies for myofascial pain control.

Authors:  Li-Wei Chou; Mu-Jung Kao; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

8.  Remote subcutaneous needling to suppress the irritability of myofascial trigger spots: an experimental study in rabbits.

Authors:  Zhonghua Fu; Yueh-Ling Hsieh; Chang-Zern Hong; Mu-Jung Kao; Jaung-Geng Lin; Li-Wei Chou
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-25       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.